Hungary's University of Szeged and the Victor Babes University of Medicine and Pharmacy in Romania are partnering with the OncoHelp Association on a research project to reduce antibiotic resistance, the Hungarian school told MTI.
The project, which runs until 2028, is funded with EUR 2.3 million from the European Union and the governments of Hungary and Romania.
Aaccording to a summary published on the website of the Univesity of Szeged, the aim of the project is to improve healthcare by purchasing new equipment and developing new techniques:
The testing methods introduced by the project will contribute to more effective diagnostics, patient care, and research. Nanopore sequencing enables the determination of DNA/RNA sequences, thus allowing real-time pathogen analysis within 24 hours. In addition, infrared spectroscopy-based biotyping, which will be introduced as part of the project, will facilitate rapid monitoring of hospital infections, resistance genes, and virulence factors, enabling real-time epidemiological investigations. The LC-MS system offers cost-effective antibiotic level determination in patients' blood, improving clinical and scientific processes.
METAGEN addresses the lack of expertise in bacterial genome sequencing by deepening the knowledge of healthcare providers.
The antibiotic resistance gene database covering the implementation area created during the project will help to accurately map the real healthcare situation, assess the status, and make evidence-based decisions.
Top 5 Articles
Duna House Profit Climbs Nearly 70% in Q3 November 24, 2025 
What Awaits the Hungarian Economy in 2026 and 2027? April 24, 2026 
'Recharge' Campaign Launched to Boost Domestic Tourism January 21, 2026 
Richter Earnings Slip as Financial Loss Weighs November 6, 2025 
Hungary’s Growth Stalls as Inflation Returns to Target Range February 6, 2026
